A Promising but Incomplete Picture
Recent research suggests that cannabis users may experience better outcomes when battling COVID-19. A study published in the journal Cannabis and Cannabinoid Research analyzed data from the National Inpatient Sample Database and found that cannabis users had lower rates of severe infections, intubation, and death compared to non-users. Specifically, the mortality rate among non-users was 5.1%, nearly double the 2.8% observed in cannabis users. Additionally, cannabis users tended to have shorter hospital stays.
However, experts urge caution in interpreting these results. The study has limitations, including challenges in adequately matching study subjects and the absence of crucial data on patient inflammation levels and specific cannabis products used. Further research is needed to fully understand the potential benefits and risks of cannabis use in relation to COVID-19.
Previous research also supports a potential association between cannabis and reduced COVID-19 severity. A 2022 study showed that certain cannabinoid acids in cannabis could prevent the SARS-CoV-2 virus from entering human cells in vitro. However, other studies have presented mixed views, with some suggesting that cannabis use might increase the risk of severe COVID-19.
As cannabis research progresses, more studies are vital to fully understand its potential health benefits and risks, particularly given the long history of prohibition that has stifled scientific exploration in this emerging field.